Following are the important reports carried by leading financial dailies and post market business news:

Business Standard

Ashok Leyland-Nissan launches LCV 'Partner'
Hinduja Group flagship company Ashok Leyland today launched Partner, a light commercial vehicle (LCV), priced in the range of Rs 8.73-9.29 lakh (ex-showroom Delhi). After the commercially successful Dost and the recently launched Stile, Partner is the latest offering from the Ashok Leyland-Nissan Joint Venture, the company said in a statement.

Tata Steel's India production and sales hit record in 2013-14
Tata Steel today said both its domestic annual production and sales hit record levels in 2013-14 at 9.15 million tonnes and 8.52 million tonnes, respectively. ''Tata Steel completed FY14 with an overall increase in production and sales volumes. The company registered its best ever performance in hot metal, crude steel, saleable steel production and total sales,'' it said in a statement.

Lupin recalls over 9,000 bottles of anti-infective Suprax from US
Lupin Ltd is recalling 9,210 bottles of infection-preventing drug Suprax which failed a purity test in the United States, the US Food and Drug Administration said. The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year because of discoloration.

Business Line

Apollo Tyres bullish on export revenue
Apollo Tyres is expecting 50% increase in export revenue from Asia Pacific, West Asia and North African markets in this fiscal, according to President Satish Sharma. The region contributes around 11% of the company's turnover of Rs 85.07 billion (2012-13). ''Our spade work for nearly two years in these markets will start yielding results from this quarter,'' Sharma said.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.